Mezzion Pharma Co.,Ltd. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported negative sales was KRW 0.00001 million. Net loss was KRW 13,602.67 million compared to KRW 13,829.31 million a year ago.

Basic loss per share from continuing operations was KRW 509.6667 compared to KRW 533.6667 a year ago. Diluted loss per share from continuing operations was KRW 509.6667 compared to KRW 533.6667 a year ago. Basic loss per share was KRW 509.6667 compared to KRW 531.6667 a year ago.

Diluted loss per share was KRW 509.6667 compared to KRW 531.6667 a year ago.